Dapagliflozin 5mg and Sitagliptin Phosphate 50 mg Tablets, available under the brand name ST- GLIPTIN DAPA 50/5 by Steris Healthcare Pvt. Ltd., is an advanced combination therapy designed for the effective management of Type 2 Diabetes Mellitus. This dual-action formulation combines two powerful anti-diabetic agents that work through different mechanisms to provide better blood sugar control.
In India, the increasing prevalence of diabetes due to sedentary lifestyles, unhealthy eating habits, and genetic factors has made combination therapies like ST- GLIPTIN DAPA 50/5 highly valuable. This medicine helps improve glycemic control when diet and exercise alone are not sufficient.
ST- GLIPTIN DAPA 50/5 is primarily prescribed for:
This medication is not recommended for Type 1 diabetes or diabetic ketoacidosis.
This combination works through two different pathways:
By targeting multiple aspects of glucose regulation, it ensures more stable and consistent sugar levels throughout the day.
Dapagliflozin may help in mild weight reduction, which is beneficial for many diabetic patients.
Compared to some traditional therapies, this combination has a lower risk of causing dangerously low blood sugar when used appropriately.
It may provide additional heart health benefits, especially in patients at risk of cardiovascular diseases.
The dosage of ST- GLIPTIN DAPA 50/5 should always be taken as prescribed by a healthcare professional.
Like all medications, Dapagliflozin 5mg and Sitagliptin 50 mg Tablets may cause some side effects.
If any severe symptoms occur, consult your doctor immediately.
Patients with kidney problems should use this medicine with caution and under medical supervision.
Since dapagliflozin increases urine output, it is important to stay well hydrated.
Use only if prescribed by a doctor during pregnancy or breastfeeding.
Limit alcohol intake as it may affect blood sugar levels.
Inform your doctor about other medications, especially anti-diabetic drugs, diuretics, or blood pressure medicines.
Regular blood sugar monitoring is essential to ensure effective treatment and avoid complications.
ST- GLIPTIN DAPA 50/5 (Dapagliflozin 5mg and Sitagliptin Phosphate 50 mg Tablets) by Steris Healthcare Pvt. Ltd. is a modern and effective combination therapy for managing Type 2 Diabetes. With its dual-action mechanism, it provides better glycemic control, supports weight management, and offers additional health benefits.
When used alongside a balanced diet, regular exercise, and proper medical guidance, this medication can significantly improve the quality of life for diabetic patients. Always follow your doctors advice and maintain regular check-ups to achieve the best outcomes in diabetes management.




Price:
Price 285 INR / Strip
Minimum Order Quantity : 1 Strip
Storage Instructions : Cool and dry place
Physical Form : Tablets
Dosage Guidelines : Direction by physician
Price 25.00 INR / Piece
Minimum Order Quantity : 1 Piece
Storage Instructions : Keep dry & cool place
Physical Form : Tablets
Dosage Guidelines : As Per Instructions
Quantity : 5000 Boxes
Price 65.00 INR / Piece
Minimum Order Quantity : 1 Piece
Storage Instructions : Keep dry & cool place
Physical Form : Tablets
Dosage Guidelines : As Per Instructions
Quantity : 5000 Boxes
Price 58.00 INR / Piece
Minimum Order Quantity : 1 Piece
Storage Instructions : Keep dry & cool place
Physical Form : Tablets
Dosage Guidelines : As Per Instructions
Quantity : 5000 Boxes